Gilad Glick
Vorstandsvorsitzender bei ITAMAR MEDICAL LTD.
Profil
Gilad Glick is currently the Chief Executive Officer at Itamar Medical Ltd.
and the Director at Beta Bionics, Inc. Previously, he served as the President & Chief Executive Officer at Itamar Medical, Inc. from 2013 to 2022.
He also held the position of Independent Director at Alameda Ventures LP from 2020 to 2022.
Additionally, he worked at Biosense Webster, Inc. as the Vice President-Sales & Marketing.
Mr. Glick obtained an MBA from Maastricht School of Management.
Aktive Positionen von Gilad Glick
| Unternehmen | Position | Beginn |
|---|---|---|
| ITAMAR MEDICAL LTD. | Vorstandsvorsitzender | 01.07.2013 |
Beta Bionics, Inc.
 Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Direktor/Vorstandsmitglied | 10.05.2022 |
Ehemalige bekannte Positionen von Gilad Glick
| Unternehmen | Position | Ende |
|---|---|---|
| ALMEDA VENTURES LIMITED PARTNERSHIP | Direktor/Vorstandsmitglied | 10.05.2022 |
Itamar Medical, Inc.
 Itamar Medical, Inc. Pharmaceuticals: MajorHealth Technology Itamar Medical, Inc. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the diagnosis of cardio logical conditions and sleep breathing disorders. The company is headquartered in Atlanta, GA. | Vorstandsvorsitzender | 01.01.2022 |
Biosense Webster, Inc.
 Biosense Webster, Inc. Medical SpecialtiesHealth Technology Biosense Webster, Inc. develops technology solutions for diagnosing heart rhythm disorders. It provides deflectable tip catheter for treating arrhythmia disorder. The company was founded by Wilton W. Webster Jr. and Shlomo Ben-Haim in 1998 and is headquartered in South Diamond Bar, CA. | Vertrieb & Marketing | - |
Ausbildung von Gilad Glick
| Maastricht School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALMEDA VENTURES LIMITED PARTNERSHIP | Finance |
| Private Unternehmen | 4 |
|---|---|
Itamar Medical Ltd.
 Itamar Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets the WatchPAT and EndoPAT products. The WatchPAT diagnoses sleep apnea, a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur in 1995 and is headquartered in Caesarea, Israel. | Electronic Technology |
Biosense Webster, Inc.
Biosense Webster, Inc. Medical SpecialtiesHealth Technology Biosense Webster, Inc. develops technology solutions for diagnosing heart rhythm disorders. It provides deflectable tip catheter for treating arrhythmia disorder. The company was founded by Wilton W. Webster Jr. and Shlomo Ben-Haim in 1998 and is headquartered in South Diamond Bar, CA. | Health Technology |
Itamar Medical, Inc.
Itamar Medical, Inc. Pharmaceuticals: MajorHealth Technology Itamar Medical, Inc. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the diagnosis of cardio logical conditions and sleep breathing disorders. The company is headquartered in Atlanta, GA. | Health Technology |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Beta Bionics, Inc. operates a medical technology company leveraging lifelong, machine-learning, artificial intelligence to develop and commercialize the autonomous bionic pancreas. The company was founded by Edward R. Damiano in October 21, 2015 and is headquartered in Boston, MA. | Health Technology |
